Transcranial Weak Current Stimulation Treatments for Working Memory Dysfunction in Schizophrenia
1 other identifier
interventional
33
1 country
1
Brief Summary
For the present study, Investigators will examine the efficacy of active prefrontal anodal tDCS versus placebo (sham) interventions to treat WM dysfunction in schizophrenia. Investigators selected the prefrontal stimulation modality that proved most effective in enhancing high-load WM performance in single dose stimulation in healthy participants . The study employs a multi-stimulation approach, with 2 sessions per day for 5 consecutive days in the active treatment group (n=15) compared to a group that receives only sham stimulation (n=15). This preliminary approach is based upon findings of a recent study applying cathodal tDCS stimulation over left temporoparietal cortex (with left prefrontal anodal stimulation) for the treatment of persistent auditory hallucinations in schizophrenia. In a a recent study clinical benefits were maintained for at least 3 months following stimulation. In the present study, in addition to clinical outcome, researchers will evaluate whether similar improvement can be obtained with WM, EEG activity, and functional outcome (e.g., discharged from hospitalization following significant improvement or remission).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable schizophrenia
Started Nov 2019
Typical duration for not_applicable schizophrenia
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 29, 2019
CompletedFirst Submitted
Initial submission to the registry
November 11, 2020
CompletedFirst Posted
Study publicly available on registry
November 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2023
CompletedSeptember 25, 2023
September 1, 2023
3.8 years
November 11, 2020
September 21, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
change in Positivie and Negative Syndrome Scale (PANSS, minimum score = 30, maximum score = 350, higher score indicate incresed ilness severity, lower scores indicate lower ilness severity) scores from baseline to post-tDCS intervention
change in total scores of the Positive and negative syndrome scale for Scizophrenia
Immediately after 10-day tDCS-intervention
change in working memory accuracy scores from baseline to post-tDCS intervention
change in verbal working memory accuracy (scores range from 0 to 126 correct responses)
Immediately after 10-day tDCS intervention
change in working memory reaction times from baseline to post-tDCS intervention
change in mean reaction times of correct rsponses (i.e., hits) (measures in millisecods range from 400 to 2000 msec)
Immediately after 10-day tDCS intervention
Secondary Outcomes (3)
change in Mismatch neagtivity (MMN) event related potentials from baseline to post-tDCS intervention
Imediatly after after 10-dat tDCS intervention
change from baseline to post-tDCS intervention in Induced EEG theta power folowing verbal command
Immediatly after tDCS intervention
change from baseline to post-tDCS intervention in Induced EEG alpha power folowing verbal command
Immediatly after tDCS intervention
Study Arms (2)
active tDCS
EXPERIMENTALactive prefrotal tDCS: 20 mins pes tDCS session, twice a day for 5 days. Total of 10 ative tDCS sessions.
Sham tDCS
SHAM COMPARATORSham prefrontal tDCS: sham stimulation 20 mins per session, twice a day for 5 days. Total of 10 sham stimulation sessions
Interventions
10 sessions of Anodal tDCS of the dorsolateral prefrontal cortex over a period of 5 consecutive days (two session a day). Each session includes the placement of two tDCS electrodes (anodal at left prefrontal area and cathodal above the vertex) and 20 mins of anodal prefrontal stimulation. The tDCS session is received two time a day with a 3-5 hours interveal betwen sessions.
Eligibility Criteria
You may qualify if:
- Ages 18-75
- Primary diagnosis of DSM-IV schizophrenia (including schizoaffective disorder)
- Right handed
- Under stable doses of antipsychotic medication for ≥4 weeks
- Normal vision by self report and physical exam
- Use of effective method of birth control for women of childbearing capacity
- Willing/capacity to provide informed consent
- Outpatients or volunteering inpatients or involuntary patients with consent of legal guardian.
You may not qualify if:
- Current or past history of substance dependence or abuse (excluding nicotine)
- Other current Axis I disorders
- History of seizure, epilepsy in self or first degree relatives, stoke, brain surgery, head injury, intracranial metal implants, known structural brain lesion, devices that may be affected by tDCS (pacemaker, medication pump, cochlear implant, implanted brain stimulator)
- Frequent and persistent migraines
- History of adverse reaction to neurostimulation
- Participation in study of investigational medication within 6 weeks
- Pregnancy
- Women who are breast-feeding
- Current significant laboratory abnormality
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oded Meironlead
Study Sites (1)
Herzog Medical Center
Jerusalem, 91035, Israel
Related Publications (3)
Brunelin J, Mondino M, Gassab L, Haesebaert F, Gaha L, Suaud-Chagny MF, Saoud M, Mechri A, Poulet E. Examining transcranial direct-current stimulation (tDCS) as a treatment for hallucinations in schizophrenia. Am J Psychiatry. 2012 Jul;169(7):719-24. doi: 10.1176/appi.ajp.2012.11071091.
PMID: 22581236BACKGROUNDMeiron O, Yaniv A, Rozenberg S, David J. Transcranial direct-current stimulation of the prefrontal cortex enhances working memory and suppresses pathological gamma power elevation in schizophrenia. Expert Rev Neurother. 2024 Feb;24(2):217-226. doi: 10.1080/14737175.2023.2294150. Epub 2024 Feb 6.
PMID: 38084398DERIVEDMeiron O, David J, Yaniv A. Left prefrontal transcranial direct-current stimulation reduces symptom-severity and acutely enhances working memory in schizophrenia. Neurosci Lett. 2021 Jun 11;755:135912. doi: 10.1016/j.neulet.2021.135912. Epub 2021 Apr 21.
PMID: 33894334DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alex Borochov, MD
Herzog Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Non-invasive Brain Stimulation Clinic
Study Record Dates
First Submitted
November 11, 2020
First Posted
November 20, 2020
Study Start
November 29, 2019
Primary Completion
August 30, 2023
Study Completion
September 10, 2023
Last Updated
September 25, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
non personal coded data indicating the participants change in working memory scores, change in psychosis severiry PANSS scores, and change in MMN amplitudes: comparing active tDCS group versus shham-tDCS group